BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Azran S, Förster D, Danino O, Nadel Y, Reiser G, Fischer B. Highly efficient biocompatible neuroprotectants with dual activity as antioxidants and P2Y receptor agonists. J Med Chem 2013;56:4938-52. [PMID: 23751098 DOI: 10.1021/jm400197m] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Luo X, Li M, Zhan K, Yang W, Zhang L, Wang K, Yu P, Zhang L. Selective inhibition of TRPM2 channel by two novel synthesized ADPR analogues. Chem Biol Drug Des 2018;91:552-66. [PMID: 29034580 DOI: 10.1111/cbdd.13119] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
2 Jacobson KA, Paoletta S, Katritch V, Wu B, Gao ZG, Zhao Q, Stevens RC, Kiselev E. Nucleotides Acting at P2Y Receptors: Connecting Structure and Function. Mol Pharmacol 2015;88:220-30. [PMID: 25837834 DOI: 10.1124/mol.114.095711] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 9.3] [Reference Citation Analysis]
3 Meyerstein D. Is Measuring OH . Radical Scavenging a Reasonable Measurement of Antioxidant Properties? Isr J Chem 2014;54:279-83. [DOI: 10.1002/ijch.201300123] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
4 Bezold D, Dürr T, Singh J, Jessen HJ. Cyclotriphosphate: A Brief History, Recent Developments, and Perspectives in Synthesis. Chemistry 2020;26:2298-308. [PMID: 31637774 DOI: 10.1002/chem.201904433] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
5 Jiang Y, Rakesh K, Alharbi NS, Vivek H, Manukumar H, Mohammed Y, Qin H. Radical scavenging and anti-inflammatory activities of (hetero)arylethenesulfonyl fluorides: Synthesis and structure-activity relationship (SAR) and QSAR studies. Bioorganic Chemistry 2019;89:103015. [DOI: 10.1016/j.bioorg.2019.103015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
6 Azran S, Danino O, Förster D, Kenigsberg S, Reiser G, Dixit M, Singh V, Major DT, Fischer B. Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of Action. J Med Chem 2015;58:8427-43. [PMID: 26447940 DOI: 10.1021/acs.jmedchem.5b00575] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
7 Danino O, Giladi N, Grossman S, Fischer B. Nucleoside 5'-phosphorothioate derivatives are highly effective neuroprotectants. Biochem Pharmacol 2014;88:384-92. [PMID: 24548458 DOI: 10.1016/j.bcp.2014.02.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
8 Liston TE, Hinz S, Müller CE, Holstein DM, Wendling J, Melton RJ, Campbell M, Korinek WS, Suresh RR, Sethre-Hofstad DA, Gao ZG, Tosh DK, Jacobson KA, Lechleiter JD. Nucleotide P2Y1 receptor agonists are in vitro and in vivo prodrugs of A1/A3 adenosine receptor agonists: implications for roles of P2Y1 and A1/A3 receptors in physiology and pathology. Purinergic Signal 2020;16:543-59. [PMID: 33129204 DOI: 10.1007/s11302-020-09732-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hevroni BL, Major DT, Dixit M, Mhashal AR, Das S, Fischer B. Nucleoside-2′,3′/3′,5′-bis(thio)phosphate antioxidants are also capable of disassembly of amyloid beta 42 -Zn( ii )/Cu( ii ) aggregates via Zn( ii )/Cu( ii )-chelation. Org Biomol Chem 2016;14:4640-53. [DOI: 10.1039/c6ob00613b] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
10 Hu L, Feng H, Zhang H, Yu S, Zhao Q, Wang W, Bao F, Ding X, Hu J, Wang M, Xu Y, Wu Z, Li X, Tang Y, Mao F, Chen X, Zhang H, Li J. Development of Novel N-hydroxypyridone Derivatives as Potential Anti-Ischemic Stroke Agents. J Med Chem 2020;63:1051-67. [PMID: 31910018 DOI: 10.1021/acs.jmedchem.9b01338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Miras-Portugal MT, Queipo MJ, Gil-Redondo JC, Ortega F, Gómez-Villafuertes R, Gualix J, Delicado EG, Pérez-Sen R. P2 receptor interaction and signalling cascades in neuroprotection. Brain Res Bull 2019;151:74-83. [PMID: 30593879 DOI: 10.1016/j.brainresbull.2018.12.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
12 von Kügelgen I, Hoffmann K. Pharmacology and structure of P2Y receptors. Neuropharmacology 2016;104:50-61. [PMID: 26519900 DOI: 10.1016/j.neuropharm.2015.10.030] [Cited by in Crossref: 135] [Cited by in F6Publishing: 126] [Article Influence: 19.3] [Reference Citation Analysis]
13 von Kügelgen I. Pharmacology of P2Y receptors. Brain Res Bull 2019;151:12-24. [PMID: 30922852 DOI: 10.1016/j.brainresbull.2019.03.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
14 Xu Z. A review on the chemical synthesis of pyrophosphate bonds in bioactive nucleoside diphosphate analogs. Bioorg Med Chem Lett 2015;25:3777-83. [PMID: 26189080 DOI: 10.1016/j.bmcl.2015.06.094] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
15 Dutta AK, Captain I, Jessen HJ. New Synthetic Methods for Phosphate Labeling. Top Curr Chem (Z) 2017;375. [DOI: 10.1007/s41061-017-0135-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
16 Hevroni BL, Sayer AH, Blum E, Fischer B. Nucleoside-2',3'/3',5'-bis(thio)phosphate analogues are promising antioxidants acting mainly via Cu+/Fe2+ ion chelation. Inorg Chem 2014;53:1594-605. [PMID: 24410662 DOI: 10.1021/ic402671q] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
17 Förster D, Reiser G. Supportive or detrimental roles of P2Y receptors in brain pathology?--The two faces of P2Y receptors in stroke and neurodegeneration detected in neural cell and in animal model studies. Purinergic Signal 2015;11:441-54. [PMID: 26407872 DOI: 10.1007/s11302-015-9471-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]